How the product works
Triclabendazole disrupts parasite energy metabolism and microtubule formation, leading to parasite death. It is effective against both immature and adult liver flukes, making it a first-line therapy for fascioliasis.
Who it is recommended for
Clinical studies and evidence
Triclabendazole is recommended by the World Health Organization as the treatment of choice for fascioliasis. Clinical studies demonstrate high cure rates and good tolerability, including in cases resistant to other anthelmintics.
The medication provides systemic antiparasitic action across multiple life stages.
The tablets are taken orally after meals. Dosage and treatment duration are determined individually by a healthcare professional based on body weight and infection severity. Self-medication is not advised.
Contraindications:
Side effects:
